The burden of cardiovascular diseases (CVDs) among smokers is profoundly evident, cigarette smoking, a leading preventable ...

Demographics and comorbid conditions play a role in vascular health, yet their specific impact on cerebrovascular bypass patency remains unclear. An institutional database of 357 patients with ...

IRVINE, CA / ACCESS Newswire / February 28, 2025 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of venous disease, ...

Completed the acquisition of lead management portfolio of medical devices and certain related assets from Cook Medical Holdings, LLC; Announced FDA premarket approval of the Wraps ...

The FDA has authorized Humacyte to release commercial shipments –– Positive responses from surgeons and trauma centers to initial sales and ...

Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system ...

Humacyte, Inc. announced the commercial launch of Symvess, an acellular tissue engineered vessel-tyod (ATEV) indicated for use ...

Merit Medical Systems, Inc. MMSI reported fourth-quarter 2024 adjusted earnings per share (EPS) of 93 cents, up 25.7% from ...

Patient selection, imaging techniques, procedural insights, strategies for optimizing patient outcomes, and more.

These grafts have superior healing, improved tissue ingrowth, higher patency, excellent biocompatibility, and proven efficacy. HEMASHIELD PLATINUM Branch Grafts: A Graft Designed for Each ...

The global biliary stent market was valued at approximately USD 394.5 million in 2022 and is projected to grow at a healthy CAGR of over 5.5% during the forecast period from 2023 ...